Page results
-
Our outpatient clinics will remain predominantly virtual throughout the COVID-19 pandemic. Please continue to refer via the NHS e-referral service.
-
This page provides information about the WEB device and how it is used to treat cerebral (brain) aneurysms
-
UCLH has recruited the first European participant to a trial looking at treating non-hospitalised Covid-19 patients with the drug remdesivir.
-
The world’s first COVID-19 vaccine study researching alternating doses and intervals of approved vaccines is taking place at UCLH.
-
In a major study involving UCLH a third of people who took a new drug for treating obesity lost more than one-fifth of their total body weight.
-
A front page story and patient case study highlight SUMMIT Study early diagnosis outcomes.
-
John McGrath is a newly appointed governor as a stakeholder member from North Central London Clinical Commissioning Group (CCG). He is a local GP and has lived and worked in Islington for the last decade in a number of different settings, including multiple GP surgeries as a salaried doctor, local A&E departments and urgent care.
-
Bladder cancer is where a growth of abnormal tissue, known as a tumour, develops in the bladder lining. In some cases, the tumour spreads into the surrounding areas.
-
A national study with initial results shows steroid dexamethasone may substantially reduce mortality in severely ill Covid-19 patients.
-
London’s Business Design Centre opens its doors this week as a large- scale COVID-19 vaccination facility.
File results
-
FOI/2021/0650 - Cyber Essentials Accreditation/ Certification
-
FOI/2021/0657 - Patient list for Neuropsychiatry
-
FOI/2021/0653 - Patient Quality Safety Committee in July 2021
-
FOI/2021/0672 - Long Covid statistics
-
FOI/2021/0691 - MHPS investigations
-
FOI/2021/0700 - Treatment of rare diseases
-
FOI/2021/0705 - Trust's maternity services
-
FOI/2021/0658 - Food waste at the Trust
-
FOI/2021/0686 - IT security strategy
-
FOI/2021/0692 - Delayed patient discharge